Respiratory infections

Respiratory diseases often show similar symptoms, but are triggered by a variety of pathogens, such as viruses, bacteria and fungi. Rapid, comprehensive and reliable diagnostics as a basis for [...]

The COVID-19 infection figures continue to rise and with them the fear: How long can regular school operations be maintained? Experts warn of renewed school closings and recommend specific measures.

In February 2020, R-Biopharm was one of the first diagnostics companies worldwide to launch a test kit for the novel coronavirus SARS-CoV-2. Now, the test has received the CE label and is thus [...]

As temperatures grow colder, the risk of catching the flu virus and spreading the infection among the population rises as well. But what makes the influenza virus so dangerous? For Virus [...]

The year’s wet and cold season begins in October along with the annual flu season. After an extraordinarily severe flu wave in 2017/18, experts are warning that the flu should not be [...]

The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.

R-Biopharm AG today announced that it has entered into a collaboration with Bosch Healthcare Solutions. Under the agreement, R‑Biopharm AG develops, manufactures and commercializes molecular [...]

As temperatures grow colder, the risk of catching the flu virus rises as well. This year, Australia is experiencing the worst flu epidemic in 15 years. Are Europe and North America also facing [...]

The new assay RIDASCREEN ® Legionella of R-Biopharm closes the gap in test portfolio for the detection of life-threatening infectious diseases.

The RIDA®GENE real-time PCR assays  (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV)  successfully detected the suggested vaccination strains for influenca of the 2015/2016 season.